Premium
PREDICTIVE VALUE OF END‐OF‐TREATMENT POSITRON EMISSION TOMOGRAPHY SCAN AFTER DA‐EPOCH‐R IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. REAL‐LIFE EXPERIENCE
Author(s) -
Derenzini E.,
Ramadan S.,
Vanazzi A.,
Radice T.,
Avenoso D.,
Mulè A.,
Sammassimo S.,
Gigli F.,
Iannitto E.,
Consoli U.,
Patti C.,
Tarella C.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.135_2631
Subject(s) - medicine , rituximab , regimen , positron emission tomography , neutropenia , nuclear medicine , lymphoma , febrile neutropenia , stage (stratigraphy) , radiation therapy , radiology , chemotherapy , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom